Canopy Growth (CGC) EBT Margin (2019 - 2025)
Canopy Growth's (CGC) quarterly EBT Margin came in at 68.88% in Q4 2025, up 7209.0% year-on-year from 0.94% in Q4 2024, and down 3911.71% quarter-over-quarter from 1.72% in Q3 2025.
Canopy Growth (CGC) EBT Margin (2019 - 2025) Analysis & Trends
Canopy Growth has disclosed EBT Margin across 7 years of filings, most recently posting 68.88% for Q4 2025.
- EBT Margin for Q4 2025 came in at 68.88%, up 7209.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 195.3% (up 27586.0% YoY), and the FY2025 annual result was 121.43%, up 20307.0% from the prior year.
- EBT Margin came in at 68.88% for Q4 2025 at Canopy Growth, down from 1.72% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 970.82% in Q1 2025 to a low of 1971.3% in Q2 2022.
- The 5-year median for EBT Margin is 151.64% (2024), against an average of 242.62%.
- Across the five-year window, EBT Margin plunged 222407 bps in 2022 and jumped 203760 bps in 2024, its largest moves.
- Canopy Growth's EBT Margin stood at 74.62% in 2021, then plunged by 215 bps to 235.27% in 2022, then decreased by 9 bps to 256.88% in 2023, then surged by 45 bps to 140.97% in 2024, then jumped by 51 bps to 68.88% in 2025.
- The last three EBT Margin figures came in at 68.88% (Q4 2025), 1.72% (Q3 2025), and 57.17% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Canopy Growth | 11.38 Mn | -137.31 Mn | 15.39 Mn | -68.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68.88% |
| Sep 30, 2025 | -1.72% |
| Jun 30, 2025 | -57.17% |
| Mar 31, 2025 | 970.82% |
| Dec 31, 2024 | -140.97% |
| Sep 30, 2024 | -208.36% |
| Jun 30, 2024 | -162.30% |
| Mar 31, 2024 | 78.99% |
| Dec 31, 2023 | -256.88% |
| Sep 30, 2023 | -164.90% |
| Jun 30, 2023 | -9.65% |
| Mar 31, 2023 | -1,958.60% |
| Dec 31, 2022 | -235.27% |
| Sep 30, 2022 | -187.43% |
| Jun 30, 2022 | -1,971.30% |
| Mar 31, 2022 | -278.95% |
| Dec 31, 2021 | -74.62% |
| Sep 30, 2021 | -14.87% |
| Jun 30, 2021 | 252.77% |
| Mar 31, 2021 | -363.11% |